InsiderTrades.com logo
David Joseph Gaffin net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

David Gaffin Biography and Net Worth

SVP of Alkermes
David Joseph Gaffin is Senior Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary of the Company. Prior to assuming his current positions, Mr. Gaffin served as Senior Vice President and Chief Legal Officer of Alkermes, Inc. and Secretary of the Company from December 2017 to March 2018. Mr. Gaffin served as Senior Vice President and Chief Legal Officer of Alkermes, Inc. from May 2016 to December 2017. Mr. Gaffin served as Vice President, U.S. General Counsel of Alkermes, Inc., from January 2014 to May 2016. Mr. Gaffin served as Vice President, Deputy General Counsel of Alkermes, Inc. from October 2011 to January 2014. Mr. Gaffin served as Senior Director, Deputy General Counsel of Alkermes, Inc. from October 2009 to October 2011. Mr. Gaffin joined Alkermes, Inc. in 2005 as Director, Deputy General Counsel. Prior to joining the company, Mr. Gaffin held the role of Assistant General Counsel at Biogen Inc., where he provided legal counsel on product-related matters and negotiated collaboration and licensing transactions.

What is David Joseph Gaffin's net worth?

The estimated net worth of David Joseph Gaffin is at least $2.94 million as of July 29th, 2021. Mr. Gaffin owns 88,597 shares of Alkermes stock worth more than $2,942,306 as of March 30th. This net worth approximation does not reflect any other investments that Mr. Gaffin may own. Additionally, Mr. Gaffin receives a salary of $1,150,000.00 as SVP at Alkermes. Learn More about David Joseph Gaffin's net worth.

How old is David Joseph Gaffin?

Mr. Gaffin is currently 52 years old. There are 6 older executives and no younger executives at Alkermes. The oldest executive at Alkermes is Dr. Floyd E. Bloom M.D., Founder, who is 87 years old. Learn More on David Joseph Gaffin's age.

What is David Joseph Gaffin's salary?

As the SVP of Alkermes plc, Mr. Gaffin earns $1,150,000.00 per year. There are 3 executives that earn more than Mr. Gaffin. The highest earning executive at Alkermes is Mr. Richard F. Pops, Chairman & CEO, who commands a salary of $2,610,000.00 per year. Learn More on David Joseph Gaffin's salary.

How do I contact David Joseph Gaffin?

The corporate mailing address for Mr. Gaffin and other Alkermes executives is 1 BURLINGTON ROAD CONNAUGHT HOUSE, DUBLIN L2, DUBLIN 4. Alkermes can also be reached via phone at (531) 772-8000 and via email at investor_relations@alkermes.com. Learn More on David Joseph Gaffin's contact information.

Has David Joseph Gaffin been buying or selling shares of Alkermes?

David Joseph Gaffin has not been actively trading shares of Alkermes during the past quarter. Most recently, David Joseph Gaffin sold 14,000 shares of the business's stock in a transaction on Thursday, July 29th. The shares were sold at an average price of $26.00, for a transaction totalling $364,000.00. Following the completion of the sale, the senior vice president now directly owns 88,597 shares of the company's stock, valued at $2,303,522. Learn More on David Joseph Gaffin's trading history.

Who are Alkermes' active insiders?

Alkermes' insider roster includes Emily Alva (Director), David Anstice (Director), Iain Brown (CFO), Shane Cooke (Director), Wendy Dixon (Director), David Gaffin (SVP), Craig Hopkinson (EVP), Blair Jackson (COO), Michael Landine (SVP), Cato Laurencin (Director), Christian Nichols (SVP), Richard Pops (Chairman & CEO), and Nancy Wysenski (Director). Learn More on Alkermes' active insiders.

Are insiders buying or selling shares of Alkermes?

During the last year, insiders at the sold shares 8 times. They sold a total of 393,075 shares worth more than $12,938,532.90. The most recent insider tranaction occured on February, 13th when EVP Craig C Hopkinson sold 144,419 shares worth more than $5,131,207.07. Insiders at Alkermes own 4.9% of the company. Learn More about insider trades at Alkermes.

Information on this page was last updated on 2/13/2025.

David Joseph Gaffin Insider Trading History at Alkermes

See Full Table

David Joseph Gaffin Buying and Selling Activity at Alkermes

This chart shows David Joseph Gaffin's buying and selling at Alkermes by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

Alkermes Company Overview

Alkermes logo
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $33.21
Low: $33.06
High: $33.99

50 Day Range

MA: $33.45
Low: $29.47
High: $36.00

2 Week Range

Now: $33.21
Low: $22.90
High: $36.45

Volume

922,403 shs

Average Volume

1,751,921 shs

Market Capitalization

$5.40 billion

P/E Ratio

15.30

Dividend Yield

N/A

Beta

0.62